SCHEMBL3878604

SCHEMBL3878604

Cc1ccccc1-c1nc(N2CCOCC2)nc(N2CCN(c3ccccn3)CC2)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
TSHR P16473 2/20 0.52
USP2 O75604 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2C9 P11712 1/20 0.52
ALOX15 P16050 1/20 0.52
MAPK1 P28482 1/20 0.52
CYP2C19 P33261 1/20 0.52
CASP7 P55210 1/20 0.52
CLK4 Q9HAZ1 1/20 0.52
PIK3CA P42336 4/20 0.50
MTOR P42345 4/20 0.50
HPGD P15428 3/20 0.50
HSD17B10 Q99714 3/20 0.50
PIK3R1 P27986 3/20 0.50
KDM4E B2RXH2 2/20 0.50
CNR2 P34972 1/20 0.50
MAPT P10636 2/20 0.49
LMNA P02545 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3879980 0.92 CNR2 (0.51) ALDH1A1TSHRUSP2CYP1A2CYP3A4
SCHEMBL3887124 0.89 HPGD (0.50) ALDH1A1TSHRPIK3CAMTORHPGD
SCHEMBL3884243 0.88 PIK3CA (0.54) ALDH1A1TSHRPIK3CAMTORHPGD
SCHEMBL3877480 0.87 PIK3CA (0.51) ALDH1A1TSHRUSP2CYP1A2CYP3A4
SCHEMBL3878071 0.87 LRRK2 (0.51) ALDH1A1TSHRPIK3CAMTORHPGD
SCHEMBL3884202 0.87 PIK3CA (0.50) ALDH1A1TSHRPIK3CAMTORHPGD
SCHEMBL3876033 0.85 HPGD (0.50) ALDH1A1TSHRMAPK1PIK3CAMTOR
SCHEMBL3880853 0.85 ALDH1A1 (0.50) ALDH1A1TSHRCYP1A2CYP3A4MAPK1
SCHEMBL3879522 0.84 HSD17B10 (0.52) ALDH1A1TSHRALOX15MAPK1PIK3CA
SCHEMBL13761287 0.82 HTT (0.61) ALDH1A1TSHRCYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7566712-B2 Biaryl piperazinyl-pyridine analogues NEUROGEN CORPORATION (US) 2009-07-28 US disclosed
US-7566712-B2 Biaryl piperazinyl-pyridine analogues NEUROGEN CORPORATION (US) 2009-07-28 US disclosed
US-7566712-B2 Biaryl piperazinyl-pyridine analogues NEUROGEN CORPORATION (US) 2009-07-28 US disclosed
US-20070027155-A1 Biaryl piperazinyl-pyridine analogues NEUROGEN CORPORATION 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027155-A1 Biaryl piperazinyl-pyridine analogues GPR174, GPR68, PPARG ALDH1A1 920/4885TSHR 74/4885USP2 4087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.